Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2025 to 30 June 2025 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council)
Date: 2025-07-18
Institutions: Directorate-General for Health and Food Safety, European Commission
Subjects: EU Member State, drug surveillance, market approval, marketing standard, medicinal product, veterinary medicinal product, withdrawal from the market








C_202504099EN.000101.fmx.xml












Official Journal of the European Union


EN
C series













C/2025/4099


18.7.2025






Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2025 to 30 June 2025
         


(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1) or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council (2))


(C/2025/4099)

—   Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted













Date of the decision


Name of the medicinal product


INN (International Non-Proprietary Name)


Holder of the marketing authorisation


Number of the entry in the Community Register


Pharmaceutical form


ATC code (Anatomical Therapeutic Chemical Code)


Date of notification




2.6.2025


Qoyvolma


ustekinumab







Celltrion Healthcare Hungary Kft.




Váci út 1-3. WestEnd Office Building B torony, 1062 Budapest, Magyarország






EU/1/25/1925


Concentrate for solution for infusion
Solution for injection


L04AC05


13.6.2025




2.6.2025


Ryjunea


atropine sulfate







Santen Oy




Niittyhaankatu 20, 33720 Tampere, Suomi






EU/1/25/1920


Eye drops, solution


S01FA01


4.6.2025




6.6.2025


DUVYZAT


givinostat







Italfarmaco S.p.A.




Viale F. Testi, 330, 20126 Milano, Italia






EU/1/25/1930


Oral suspension


M09AX14


6.6.2025




11.6.2025


Xoanacyl


ferric citrate coordination complex







AVEROA SAS




11 Avenue Paul Verlaine, 38100 Grenoble, France






EU/1/25/1923


Film-coated tablet


V03AE08


12.6.2025




19.6.2025


Sephience


sepiapterin







PTC Therapeutics International Limited




Unit 1, 52-55 Sir John Rogerson's Quay, Dublin 2, D02 NA07, Ireland






EU/1/25/1939


White to beige oral powder in capsules for opening or sachet.


A16AX28


25.6.2025




19.6.2025


TEPEZZA


Teprotumumab







Amgen Europe B.V.




Minervum 7061, 4817 ZK Breda, Nederland






EU/1/25/1941


Powder for concentrate for solution for infusion


L04AG13


22.6.2025




23.6.2025


Junod


denosumab







Gedeon Richter Plc.




Gyömrői út 19-21, 1103 Budapest, Magyarország






EU/1/25/1933


Solution for injection


M05BX04


2.7.2025




23.6.2025


Yaxwer


denosumab







Gedeon Richter Plc.




Gyömrői út 19-21, 1103 Budapest, Magyarország






EU/1/25/1934


Solution for injection


M05BX04


25.6.2025




25.6.2025


Vevzuo


denosumab







Biosimilar Collaborations Ireland Limited




Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, D13 R20R, DUBLIN, Ireland






EU/1/25/1945


Solution for injection


M05BX04


1.7.2025




26.6.2025


Denbrayce


Denosumab







Mabxience Research SL




C/ Manuel Pombo Angulo 28, 28050 Madrid, España






EU/1/25/1936


Solution for injection


M05BX04


27.6.2025




26.6.2025


Enwylma


denosumab







Zentiva, k.s.




U Kabelovny 130, 102 37 Praha 10, Česká republika






EU/1/25/1944


Solution for injection


M05BX04


1.7.2025




26.6.2025


Izamby


denosumab







Mabxience Research SL




C/ Manuel Pombo Angulo 28, 28050 Madrid, España






EU/1/25/1935


Solution for injection


M05BX04


27.6.2025




26.6.2025


ZADENVI


denosumab







Zentiva k.s.




U kabelovny 130, 102 37 Praha 10, Česká republika






EU/1/25/1937


Solution for injection


M05BX04


1.7.2025




27.6.2025


Ziihera


zanidatamab







Jazz Pharmaceuticals Ireland Limited




5th Floor, Waterloo Exchange, Waterloo Road, Dublin 4, D04 E5W7, Ireland






EU/1/25/1931


Powder for concentrate for solution for infusion


L01FD07


30.6.2025




30.6.2025


Alyftrek


deutivacaftor/tezacaftor/vanzacaftor







Vertex Pharmaceuticals (Ireland) Limited




Unit 49, Block 5, Northwood Court, Northwood Crescent, Dublin 9, D09 T665, Ireland






EU/1/25/1943


Film-coated tablet


R07AX33


1.7.2025




30.6.2025


Dazublys


trastuzumab







CuraTeQ Biologics s.r.o




Trtinova 260/1, Cakovice, 19600 Prague 9, Česká republika






EU/1/25/1949


Powder for concentrate for solution for infusion


L01FD01


1.7.2025




30.6.2025


Evfraxy


denosumab







Biosimilar Collaborations Ireland Limited




Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, D13 R20R, DUBLIN, Ireland






EU/1/25/1946


Solution for injection


M05BX04


1.7.2025




30.6.2025


Oczyesa


octreotide







Camurus AB




Rydbergs Torg 4, 224 84 Lund, Sverige






EU/1/25/1938


Prolonged-release solution for injection


H01CB02


1.7.2025




—   Modification of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted










Date of the decision


Name of the medicinal product


Holder of the marketing authorisation


Number of the entry in the Community Register


Date of notification




2.6.2025


ADCETRIS







Takeda Pharma A/S




Delta Park 45, 2665 Vallensbaek Strand, Danmark






EU/1/12/794


3.6.2025




2.6.2025


ARIKAYCE liposomal







Insmed Netherlands B.V.




Stadsplateau 7, 3521 AZ Utrecht, Nederland






EU/1/20/1469


3.6.2025




2.6.2025


Bosulif







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/13/818


3.6.2025




2.6.2025


Calquence







AstraZeneca AB




151 85 Södertälje, Sverige






EU/1/20/1479


3.6.2025




2.6.2025


Evrysdi







Roche Registration GmbH




Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland






EU/1/21/1531


3.6.2025




2.6.2025


Fasturtec







Sanofi Winthrop Industrie




82 avenue Raspail, 94250 Gentilly, France






EU/1/00/170


3.6.2025




2.6.2025


Jivi







Bayer AG




D-51368 Leverkusen, Deutschland






EU/1/18/1324


3.6.2025




2.6.2025


Jyseleca







Alfasigma S.p.A.




Via Ragazzi del '99, n.5, 40133 Bologna, Italia






EU/1/20/1480


3.6.2025




2.6.2025


Lytgobi







Taiho Pharma Netherlands B.V.




Barbara Strozzilaan 201, 1083 HN Amsterdam, Noord-Holland, Nederland






EU/1/23/1741


3.6.2025




2.6.2025


Qdenga







Takeda GmbH




Byk-Gulden-Straße 2, 78467 Konstanz, Deutschland






EU/1/22/1699


3.6.2025




2.6.2025


RINVOQ







AbbVie Deutschland GmbH & Co. KG




Knollstrasse, 67061 Ludwigshafen, Deutschland






EU/1/19/1404


3.6.2025




2.6.2025


Rozlytrek







Roche Registration GmbH




Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland






EU/1/20/1460


3.6.2025




2.6.2025


TALVEY







Janssen-Cilag International NV




Turnhoutseweg 30, 2340 Beerse, België






EU/1/23/1748


3.6.2025




2.6.2025


Ultomiris







Alexion Europe SAS




103-105 Rue Anatole France, 92300 Levallois-Perret, France






EU/1/19/1371


3.6.2025




2.6.2025


VEGZELMA







Celltrion Healthcare Hungary Kft.




Váci út 1-3. WestEnd Office Building B torony, 1062 Budapest, Magyarország






EU/1/22/1667


10.6.2025




2.6.2025


VELCADE







Janssen-Cilag International NV




Turnhoutseweg 30, 2340 Beerse, België






EU/1/04/274


3.6.2025




2.6.2025


ZTALMY







Immedica Pharma AB




SE-113 63, Stockholm, Sverige






EU/1/23/1743


16.6.2025




4.6.2025


Tivdak







Genmab A/S




Carl Jacobsens Vej 30, 2500 Valby, Danmark






EU/1/25/1911


5.6.2025




5.6.2025


Amvuttra







Alnylam Netherlands B.V.




Antonio Vivaldistraat 150, 1083 HP Amsterdam, Nederland






EU/1/22/1681


6.6.2025




5.6.2025


Aybintio







Samsung Bioepis NL B.V.




Olof Palmestraat 10, 2616 LR Delft, Nederland






EU/1/20/1454


9.6.2025




5.6.2025


Bemfola







Gedeon Richter Plc.




Gyömrői út 19-21, 1103 Budapest, Magyarország






EU/1/13/909


12.6.2025




5.6.2025


Trodelvy







Gilead Sciences Ireland UC




Carrigtohill, County Cork, T45 DP77, Ireland






EU/1/21/1592


6.6.2025




6.6.2025


Cabazitaxel Accord







Accord Healthcare S.L.U.




World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España






EU/1/20/1448


10.6.2025




6.6.2025


Cystadrops







Recordati Rare Diseases




Tour Hekla, 52 avenue du Général de Gaulle, F-92800 Puteaux, France






EU/1/15/1049


10.6.2025




6.6.2025


Fingolimod Mylan







Mylan Pharmaceuticals Limited




Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland






EU/1/21/1573


10.6.2025




6.6.2025


Flixabi







Samsung Bioepis NL B.V.




Olof Palmestraat 10, 2616 LR Delft, Nederland






EU/1/16/1106


11.6.2025




6.6.2025


ORSERDU







Stemline Therapeutics B.V.




Basisweg 10, 1043 AP, Amsterdam, Noord-Holland, Nederland






EU/1/23/1757


10.6.2025




6.6.2025


Pregabalin Viatris Pharma







Viatris Healthcare Limited




Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland






EU/1/14/916


18.6.2025




6.6.2025


Sugammadex Mylan







Mylan Pharmaceuticals Limited




Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland






EU/1/21/1583


10.6.2025




6.6.2025


Sugammadex Piramal







Piramal Critical Care B.V.




Rouboslaan 32 (ground floor), 2252 TR, Voorschoten, Nederland






EU/1/23/1739


15.5.2025




6.6.2025


Sugammadex Piramal







Piramal Critical Care B.V.




Rouboslaan 32 (ground floor), 2252 TR, Voorschoten, Nederland






EU/1/23/1739


11.6.2025




6.6.2025


Veklury







Gilead Sciences Ireland UC




Carrigtohill, County Cork, T45 DP77, Ireland






EU/1/20/1459


11.6.2025




6.6.2025


Velsipity







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/23/1790


10.6.2025




12.6.2025


Atriance







Sandoz Pharmaceuticals d.d.




Verovškova ulica 57, 1000 Ljubljana, Slovenija






EU/1/07/403


18.6.2025




12.6.2025


Elfabrio







Chiesi Farmaceutici S.p.A.




Via Palermo 26/A, 43122 Parma, Italia






EU/1/23/1724


13.6.2025




12.6.2025


Emtricitabine /Tenofovir disoproxil Krka d.d.







KRKA d d., Novo mesto




Šmarješka cesta 6, 8501 Novo mesto, Slovenija






EU/1/17/1182


13.6.2025




12.6.2025


Inflectra







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/13/854


13.6.2025




12.6.2025


Oncaspar


Les Laboratoires Servier
50 rue Carnot, 92284 Suresnes Cedex, France


EU/1/15/1070


13.6.2025




12.6.2025


Pregabalin Viatris Pharma







Viatris Healthcare Limited




Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland






EU/1/14/916


16.6.2025




12.6.2025


Xgeva







Amgen Europe B.V.




Minervum 7061, 4817 ZK Breda, Nederland






EU/1/11/703


15.6.2025




12.6.2025


Zoonotic Influenza Vaccine Seqirus







Seqirus S.r.l.




Via del Pozzo 3/A, S. Martino, 53035 Monteriggioni (SI), Italia






EU/1/23/1761


13.6.2025




19.6.2025


Baraclude







Bristol-Myers Squibb Pharma EEIG




Plaza 254, Blanchardstown Corporate Park 2, D15 T867, Dublin 15, Ireland






EU/1/06/343


20.6.2025




19.6.2025


BEYONTTRA







Bayer AG




51368 Leverkusen, Deutschland






EU/1/24/1906


25.6.2025




19.6.2025


KEYTRUDA







Merck Sharp & Dohme B.V.




Waarderweg 39, 2031 BN Haarlem, Nederland






EU/1/15/1024


20.6.2025




19.6.2025


Omidria







Rayner Surgical (Ireland) Limited




The Mill Enterprise Hub, Newtown Link Road, Drogheda, A92 CD3D, Co. Louth, Ireland






EU/1/15/1018


7.7.2025




19.6.2025


Talzenna







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/19/1377


20.6.2025




19.6.2025


Vyvgart


argenx BV
Industriepark-Zwijnaarde 7, 9052 Gent, België


EU/1/22/1674


20.6.2025




23.6.2025


Adempas







Bayer AG




D-51368 Leverkusen, Deutschland






EU/1/13/907


24.6.2025




23.6.2025


AKEEGA







Janssen-Cilag International NV




Turnhoutseweg 30, 2340 Beerse, België






EU/1/23/1722


25.6.2025




23.6.2025


Apremilast Accord







Accord Healthcare S.L.U.




World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España






EU/1/24/1796


25.6.2025




23.6.2025


Cibinqo







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/21/1593


25.6.2025




23.6.2025


Fampridine Accord







Accord Healthcare S.L.U.




World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España






EU/1/20/1477


25.6.2025




23.6.2025


Irbesartan / Hydrochlorothiazide Teva







Teva B.V.




Swensweg 5, 2031 GA Haarlem, Nederland






EU/1/09/583


26.6.2025




23.6.2025


Leflunomide Zentiva







Zentiva k.s.




U kabelovny 130, 102 37 Praha 10, Česká republika






EU/1/09/604


27.6.2025




23.6.2025


Pombiliti







Amicus Therapeutics Europe Limited




Block 1, Blanchardstown Corporate Park, Ballycoolin Road, Blanchardstown, Dublin D15 AKK1, Ireland






EU/1/22/1714


25.6.2025




23.6.2025


Poteligeo







Kyowa Kirin Holdings B.V.




Bloemlaan 2, 2132 NP Hoofddorp, Nederland






EU/1/18/1335


30.6.2025




23.6.2025


Respreeza







CSL Behring GmbH




Emil-von-Behring-Straße 76, 35041 Marburg, Deutschland






EU/1/15/1006


26.7.2025




23.6.2025


Sogroya







Novo Nordisk A/S




Novo Allé, 2880 Bagsvaerd, Danmark






EU/1/20/1501


25.6.2025




23.6.2025


Sugammadex Amomed







AOP Orphan Pharmaceuticals GmbH




Leopold-Ungar-Platz 2, 1190 Wien, Österreich






EU/1/22/1708


3.6.2025




23.6.2025


Sugammadex Amomed







AOP Orphan Pharmaceuticals GmbH




Leopold-Ungar-Platz 2, 1190 Wien, Österreich






EU/1/22/1708


25.6.2025




23.6.2025


Tepkinly







AbbVie Deutschland GmbH & Co. KG




Knollstrasse, 67061 Ludwigshafen, Deutschland






EU/1/23/1759


25.6.2025




23.6.2025


Vfend







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/02/212


25.6.2025




25.6.2025


Amlodipine/Valsartan Mylan







Mylan Pharmaceuticals Limited




Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland






EU/1/16/1092


27.6.2025




25.6.2025


Avamys







GlaxoSmithKline Trading Services Limited




12 Riverwalk, Citywest Business Campus, Dublin 24, D24 YK11, Ireland






EU/1/07/434


30.6.2025




25.6.2025


Cufence







Univar Solutions B.V.




Schouwburgplein 30, Rotterdam, 3012 CL, Nederland






EU/1/19/1365


1.7.2025




25.6.2025


Eylea







Bayer AG




D-51368 Leverkusen, Deutschland






EU/1/12/797


26.6.2025




25.6.2025


HyQvia







Baxalta Innovations GmbH




Industriestraße 67, 1221 Wien, Österreich






EU/1/13/840


27.6.2025




25.6.2025


Idefirix







Hansa Biopharma AB




P.O. Box 785, 220 07 Lund, Sverige






EU/1/20/1471


27.6.2025




25.6.2025


Jivi







Bayer AG




D-51368 Leverkusen, Deutschland






EU/1/18/1324


26.6.2025




25.6.2025


ProQuad







Merck Sharp & Dohme B.V.




Waarderweg 39, 2031 BN Haarlem, Nederland






EU/1/05/323


27.6.2025




25.6.2025


Raxone







Chiesi Farmaceutici S.p.A.




Via Palermo 26/A, 43122 Parma, Italia






EU/1/15/1020


26.6.2025




25.6.2025


Saxenda







Novo Nordisk A/S




Novo Allé, 2880 Bagsvaerd, Danmark






EU/1/15/992


26.6.2025




25.6.2025


Torisel







Pfizer Europe MA EEIG




Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/ Pleinlaan 17, 1050 Brussel, België






EU/1/07/424


26.6.2025




27.6.2025


Camcevi







Accord Healthcare S.L.U.




World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España






EU/1/22/1647


30.6.2025




27.6.2025


Hycamtin







Sandoz Pharmaceuticals d.d.




Verovškova ulica 57, 1000 Ljubljana, Slovenija






EU/1/96/027


30.6.2025




27.6.2025


Kapruvia







Vifor Fresenius Medical Care Renal Pharma France




100-101 terrasse Boieldieu, Tour Franklin La Défense 8, 92042 Paris la Défense Cedex, France






EU/1/22/1643


30.6.2025




27.6.2025


Pedmarqsi







Norgine B.V.




Antonio Vivaldistraat 150, 1083 HP Amsterdam, Nederland






EU/1/23/1734


1.7.2025




—   Withdrawal of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)









Date of the decision


Name of the medicinal product


Holder of the marketing authorisation


Number of the entry in the Community Register


Date of notification




19.6.2025


BroPair Spiromax







Teva B.V.




Swensweg 5, 2031 GA Haarlem, Nederland






EU/1/21/1534


25.6.2025




19.6.2025


Sixmo







L. Molteni & C. dei F.lli Alitti Società di .Esercizio .S.p.A




Strada Statale 67, Loc. Granatieri, 50018 Scandicci (Firenze), Italia






EU/1/19/1369


30.6.2025




—   Issuing of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council; Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council): Accepted













Date of the decision


Name of the medicinal product


INN (International Non-Proprietary Name)


Holder of the marketing authorisation


Number of the entry in the Community Register


Pharmaceutical form


ATC code (Anatomical Therapeutic Chemical Code)


Date of notification




2.6.2025


Emevet


Maropitant







CP-Pharma Handelsgesellschaft mbH




Ostlandring 13, 31303 Burgdorf, Deutschland






EU/2/25/343


Chewable tablet


QA04AD90


4.6.2025




2.6.2025


Nobilis Multriva Gm+REOm


Avian infectious bursal disease and avian reovirus vaccine (inactivated)







Intervet International B.V.




Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland






EU/2/25/344


Emulsion for injection


QI01AA22


3.6.2025




2.6.2025


Nobilis Multriva IBm+ND


Avian infectious bronchitis virus and Newcastle disease virus vaccine (inactivated)







Intervet International B.V.




Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland






EU/2/25/342


Emulsion for injection


QI01AA10


3.6.2025




27.6.2025


Fluralaner Intervet


fluralaner







Intervet International B.V.




Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland






EU/2/25/346


Chewable tablet


QP53BE02


9.7.2025




27.6.2025


Nobilis Multriva IBm+ND+Gm+REOm+EDS


Avian infectious bronchitis, Newcastle disease, avian infectious bursal disease, avian reovirus and egg drop syndrome virus vaccine (inactivated)







Intervet International B.V.




Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland






EU/2/25/345


Emulsion for injection


QI01AA25


1.7.2025




—   Modification of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council; Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council): Accepted










Date of the decision


Name of the medicinal product


Holder of the marketing authorisation


Number of the entry in the Community Register


Date of notification




2.6.2025


Vectormune ND







CEVA-Phylaxia Co. Ltd




Szállás u. 5, 1107 Budapest, Magyarország






EU/2/15/188


4.6.2025




27.6.2025


Coxatab







CP-Pharma Handelsgesellschaft mbH




Ostlandring 13, 31303 Burgdorf, Deutschland






EU/2/22/286


1.7.2025




27.6.2025


DIVENCE PENTA







Laboratorios Hipra, S.A.




Avda. La Selva, 135, 17170 Amer (Girona), España






EU/2/24/307


2.7.2025




27.6.2025


HorStem







EquiCord S.L.




103-D Loeches, Polígono Industrial Ventorro del Cano, Alcorcón, 28925 Madrid, España






EU/2/18/226


2.7.2025




27.6.2025


Melovem







Dopharma Research B.V.




Zalmweg 24, 4941 VX Raamsdonksveer, Nederland






EU/2/09/098


2.7.2025




27.6.2025


Mirataz







Dechra Regulatory B.V.




Handelsweg 25, 5531 AE Bladel, Nederland






EU/2/19/247


4.7.2025




27.6.2025


NexGard Combo







Boehringer Ingelheim Vetmedica GmbH




D-55216 Ingelheim am Rhein, Deutschland






EU/2/20/267


30.6.2025




27.6.2025


Oncept IL-2







Boehringer Ingelheim Vetmedica GmbH




D-55216 Ingelheim am Rhein, Deutschland






EU/2/13/150


30.6.2025




27.6.2025


Profender







Vetoquinol S.A.




Magny-Vernois, 70200 Lure, France






EU/2/05/054


30.6.2025




27.6.2025


Stronghold Plus







Zoetis Belgium




rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique






EU/2/16/204


30.6.2025




Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:





European Medicines Agency




Domenico Scarlattilaan 6




1083 HS Amsterdam




NETHERLANDS






(1)  
            OJ L 136, 30.4.2004, p. 1, ELI: https://data.europa.eu/eli/reg/2004/726/oj.

(2)  
            OJ L 4, 7.1.2019, p. 43, ELI: https://data.europa.eu/eli/reg/2019/6/oj.


ELI: http://data.europa.eu/eli/C/2025/4099/oj
ISSN 1977-091X (electronic edition)